Top Markets
Coin of the day
Manzo Pharmaceuticals, Inc. Manzo Pharmaceuticals, Inc.

Manzo Pharmaceuticals, Inc.

MNZO
Rank in Stocks #40587
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the... Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.
Share Price
$0.0001
Last synced: 2026-08-12
Market Cap
$115.95K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Manzo Pharmaceuticals, Inc. (MNZO)

Category

Operating Margin for Manzo Pharmaceuticals, Inc. (MNZO)
Operating Margin as of 2026 TTM: 0.00%
According to Manzo Pharmaceuticals, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Manzo Pharmaceuticals, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
23.18% -
IN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.